In clinical trials, non-diabetic individuals taking semaglutide experienced significant weight loss, with average weight loss ranging from 10% to 15% of initial body weight over 6-12 months of treatment
Reduced food intake further decreases dietary vitamin D sources
Following the assessment, patients schedule a telehealth consultation with a licensed healthcare provider
At the cellular level, GLP-1 receptor activation appears to reduce the production of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-), interleukin-6 (IL-6), and interleukin-1 beta (IL-1)
Han, M., Tang, X., Yin, H